Joseph Hargett

Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street JournalThe New York TimesMoney Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Friday’s Vital Data: Apple Inc. (AAPL), Bank of America Corp (BAC) and Valeant Pharmaceuticals Intl Inc (VRX)

Apple (AAPL) options dip on a price target cut, Bank of America (BAC) earnings expectations are lowered and Valeant (VRX) cuts a deal with creditors.

Thursday’s Vital Data: Apple Inc. (AAPL), Facebook Inc (FB) and Tesla Motors Inc (TSLA)

Apple (AAPL) options soar on a strong buy initiation, Tesla (TSLA) surges despite a production miss and Facebook (FB) buys content for Facebook Live.

Wednesday’s Vital Data: Pfizer Inc. (PFE), Allergan plc Ordinary Shares (AGN) and AT&T Inc. (T)

Options activity spiked on Pfizer (PFE) and Alergan (AGN) as their merger deal fell apart, while AT&T (T) call volume soared ahead of T’s ex-dividend.

Tuesday’s Vital Data: Apple Inc. (AAPL), Facebook Inc (FB) and Twitter Inc (TWTR)

Apple (AAPL) options rise on Credit Suisse’s bullish comments, Facebook (FB) sees mixed analyst action and Twitter (TWTR) could partner with MasterCard (MA).

Rite Aid Corporation: 2 Trades for Drifting RAD Stock

With the Walgreen's merger deal still pending approval, RAD stock has been left to drift heading into Rite Aid earnings. But there are still ways to profit.